Samsung Biologics Discloses Initial Issue Price for Capital Increase
MT Newswires Live
Yesterday
Samsung Biologics (KRX:207940) said the preliminary issue price for its capital increase will be nearly 1.2 million won per share.
The final issue price is scheduled to be released Nov. 5, a Thursday bourse filing showed.
The capital increase was first announced in August.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.